Canaccord analyst Richard Close lowered the firm’s price target on Progyny (PGNY) to $17 from $18 and keeps a Hold rating on the shares. The firm lowered its estimates after another quarter falling short of expectations and lowering of guidance.
Canaccord analyst Richard Close lowered the firm’s price target on Progyny (PGNY) to $17 from $18 and keeps a Hold rating on the shares. The firm lowered its estimates after another quarter falling short of expectations and lowering of guidance.